Ocular allergic inflammation: Interaction between the cornea and conjunctiva

Cornea

Volumn 29, Issue SUPPL. 1, 2010, Pages

  Fukuda, Ken ^a,b   Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

allergy; conjunctiva; cornea; eosinophil; vernal keratoconjunctivitis

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; EOTAXIN; GELATINASE B; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; MAJOR BASIC PROTEIN;

BASEMENT MEMBRANE; CELL FUNCTION; CELL GRANULE; CONFERENCE PAPER; CONJUNCTIVA; CORNEA; CORNEA EPITHELIUM; CORNEA STROMA; CORNEA ULCER; CYTOTOXICITY; EOSINOPHIL; EPITHELIUM CELL; EYE ALLERGY; EYE INFLAMMATION; FIBROBLAST; HUMAN; LYMPHOCYTIC INFILTRATION; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; TH2 CELL; VERNAL CONJUNCTIVITIS; WOUND HEALING;

ANIMALS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CORNEAL DISEASES; EOSINOPHILS; EPITHELIUM, CORNEAL; HUMANS; TH2 CELLS;

EID: 78649275640     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181ea9b2b     Document Type: Conference Paper

References (33)

1. Kumagai N, Fukuda K, Fujitsu Y, et al. Treatment of corneal lesions in individuals with vernal keratoconjunctivitis. Allergol Int. 2005;54:51-59.
2. Cameron JA. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology. 1995;102:985-993.
3. Solomon A, Zamir E, Levartovsky S, et al. Surgical management of corneal plaques in vernal keratoconjunctivitis: A clinicopathologic study. Cornea. 2004;23:608-612.
4. Trocme SD, Aldave AJ. The eye and the eosinophil. Surv Ophthalmol. 1994;39:241-252.
5. Trocme SD, Hallberg CK, Gill KS, et al. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci. 1997;38:593-599.
6. Trocmé SD, Gleich GJ, Kephart GM, et al. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1994;35:3051-3056.
7. Leonardi A, Brun P, Abatangelo G, et al. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052-3058.
8. Trocmé SD, Kephart GM, Bourne WM, et al. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol. 1993;115:640-643.
9. Fukuda K, Chikama T, Nakamura M, et al. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73-79.
10. Abu El-Asrar AM, Van Aelst I, Al-Mansouri S, et al. Gelatinase B in vernal keratoconjunctivitis. Arch Ophthalmol. 2001;119:1505-1511.
11. Kumagai N, Yamamoto K, Fukuda K, et al. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol. 2002;110:489-491.
12. Fukagawa K, Nakajima T, Tsubota K, et al. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol. 1999;103:1220-1221.
13. Leonardi A, Curnow SJ, Zhan H, et al. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy. 2006;36:777-784.
14. Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol. 1991;146:1169-1174.
15. Fukuda K, Fujitsu Y, Kumagai N, et al. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:183-188.
16. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, et al. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest. 1998;101:2129-2139.
17. Schnyder B, Lugli S, Feng N, et al. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood. 1996;87:4286-4295.
18. Vita N, Lefort S, Laurent P, et al. Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem. 1995;270:3512-3517.
19. Kumagai N, Fukuda K, Fujitsu Y, et al. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis. Prog Retin Eye Res. 2006;25:165-187.
20. Kumagai N, Fukuda K, Ishimura Y, et al. Synergistic induction of eotaxin expression in human keratocytes by TNF-a and IL-4 or IL-13. Invest Ophthalmol Vis Sci. 2000;41:1448-1453.
21. Fukagawa K, Nakajima T, Saito H, et al. IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int Arch Allergy Immunol. 2000;121:144-150.
22. Fukagawa K, Okada N, Fujishima H, et al. Corneal and conjunctival fibroblasts are major sources of eosinophil-recruiting chemokines. Allergol Int. 2009;58:499-508.
23. Fukuda K, Yamada N, Fujitsu Y, et al. Inhibition of eotaxin expression in human corneal fibroblasts by interferon-g. Int Arch Allergy Immunol. 2002;129:138-144.
24. Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF-a and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000;279:1-5.
25. Fukuda K, Fujitsu Y, Seki K, et al. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol. 2003;111:520-526.
26. Sekiya T, Miyamasu M, Imanishi M, et al. Inducible expression of a Th2- type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol. 2000;165:2205-2213.
27. Vestergaard C, Bang K, Gesser B, et al. A TH2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol. 2000;115:640-646.
28. Yokoi K, Yokoi N, Kinoshita S. Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis. Br J Ophthalmol. 1998; 82:797-800.
29. Kimura K, Teranishi S, Fukuda K, et al. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-a in a manner dependent on NF-kB. Invest Ophthalmol Vis Sci. 2008;49:565-571.
30. Kimura K, Teranishi S, Nishida T. Interleukin-1b-induced disruption of barrier function in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2009;50:597-603.
31. Ebihara N, Funaki T, Murakami A, et al. Mast cell chymase decreases the barrier function and inhibits the migration of corneal epithelial cells. Curr Eye Res. 2005;30:1061-1069.
32. Fukuda K, Nishida T. Reciprocal interaction of the conjunctiva and cornea in ocular allergy. J Allergy Clin Immunol. 2010;125:493-496.
33. Fukushima A, Ozaki A, Fukata K, et al. Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:4366-4374.